Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |